Biotech firm Insys Therapeutics shares drop as sales-practice concerns resurface – CNBC


CNBC
Biotech firm Insys Therapeutics shares drop as sales-practice concerns resurface
CNBC
NBC News, citing a whistleblower, reported a powerful opioid had been prescribed to patient who shouln’t have taken it. Entering Monday’s session, Insys shares had risen more than 53 percent, making it one of the best-performing stocks in the iShares¬†…

and more >>

Source: shares – Google News

Sharing information is key – Share Dealing Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd